颧骨种植体支撑假体的长期成功率和生物学并发症分析

IF 0.8 Q3 Pharmacology, Toxicology and Pharmaceutics Journal of Pharmacy and Bioallied Sciences Pub Date : 2024-06-07 DOI:10.4103/jpbs.jpbs_308_24
K. Dash, Kondeti Naga Venkata Lakshmi Praveena, Samir Mansuri, Rozina Hussain Ali, Kunchala Sailasri, Shivani Karre, Anil Managutti
{"title":"颧骨种植体支撑假体的长期成功率和生物学并发症分析","authors":"K. Dash, Kondeti Naga Venkata Lakshmi Praveena, Samir Mansuri, Rozina Hussain Ali, Kunchala Sailasri, Shivani Karre, Anil Managutti","doi":"10.4103/jpbs.jpbs_308_24","DOIUrl":null,"url":null,"abstract":"ABSTRACT\n \n \n \n Patients with significant maxillary atrophy who are not candidates for standard implants now have an option thanks to zygomatic implants. Long-term statistics on difficulties and success are, however, scarce.\n \n \n \n A tertiary care center’s patient data were retrospectively analyzed. Included were patients who underwent zygomatic implant surgery between 2017 and 2022. This research gathered and examined data on follow-up, surgical techniques, complications, demographics, and implant features.\n \n \n \n There were 100 patients in all. 92% of the implants were successful, and 92 of them survived. Peri-implantitis (20%), soft tissue dehiscence (15%), sinusitis (10%), prosthesis fracture (8%), and infection (5%), were among the biological consequences. In summary, zygomatic implants have the potential to help individuals with severe maxillary atrophy recover, but close observation and effective management of any problems are necessary to maximize results. To enhance patient care and improve treatment regimens, further research is required.\n","PeriodicalId":16824,"journal":{"name":"Journal of Pharmacy and Bioallied Sciences","volume":" 4","pages":""},"PeriodicalIF":0.8000,"publicationDate":"2024-06-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Analysis of Long-Term Success and Biological Complications in Zygomatic Implant-Supported Prostheses\",\"authors\":\"K. Dash, Kondeti Naga Venkata Lakshmi Praveena, Samir Mansuri, Rozina Hussain Ali, Kunchala Sailasri, Shivani Karre, Anil Managutti\",\"doi\":\"10.4103/jpbs.jpbs_308_24\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"ABSTRACT\\n \\n \\n \\n Patients with significant maxillary atrophy who are not candidates for standard implants now have an option thanks to zygomatic implants. Long-term statistics on difficulties and success are, however, scarce.\\n \\n \\n \\n A tertiary care center’s patient data were retrospectively analyzed. Included were patients who underwent zygomatic implant surgery between 2017 and 2022. This research gathered and examined data on follow-up, surgical techniques, complications, demographics, and implant features.\\n \\n \\n \\n There were 100 patients in all. 92% of the implants were successful, and 92 of them survived. Peri-implantitis (20%), soft tissue dehiscence (15%), sinusitis (10%), prosthesis fracture (8%), and infection (5%), were among the biological consequences. In summary, zygomatic implants have the potential to help individuals with severe maxillary atrophy recover, but close observation and effective management of any problems are necessary to maximize results. To enhance patient care and improve treatment regimens, further research is required.\\n\",\"PeriodicalId\":16824,\"journal\":{\"name\":\"Journal of Pharmacy and Bioallied Sciences\",\"volume\":\" 4\",\"pages\":\"\"},\"PeriodicalIF\":0.8000,\"publicationDate\":\"2024-06-07\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Pharmacy and Bioallied Sciences\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.4103/jpbs.jpbs_308_24\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"Pharmacology, Toxicology and Pharmaceutics\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Pharmacy and Bioallied Sciences","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4103/jpbs.jpbs_308_24","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Pharmacology, Toxicology and Pharmaceutics","Score":null,"Total":0}
引用次数: 0

摘要

摘要 患有严重上颌骨萎缩且不适合使用标准种植体的患者现在有了颧骨种植体的选择。然而,有关手术难度和成功率的长期统计数据却很少。 我们对一家三级医疗中心的患者数据进行了回顾性分析。研究对象包括在 2017 年至 2022 年期间接受颧骨种植手术的患者。这项研究收集并检查了有关随访、手术技术、并发症、人口统计学和植入物特征的数据。 共有 100 名患者。92%的植入成功,其中92人存活。生物学后果包括种植体周围炎(20%)、软组织开裂(15%)、鼻窦炎(10%)、假体断裂(8%)和感染(5%)。总之,颧骨种植体具有帮助严重上颌骨萎缩患者恢复的潜力,但要想取得最佳效果,必须密切观察并有效处理任何问题。为了加强对患者的护理并改进治疗方案,还需要进一步的研究。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Analysis of Long-Term Success and Biological Complications in Zygomatic Implant-Supported Prostheses
ABSTRACT Patients with significant maxillary atrophy who are not candidates for standard implants now have an option thanks to zygomatic implants. Long-term statistics on difficulties and success are, however, scarce. A tertiary care center’s patient data were retrospectively analyzed. Included were patients who underwent zygomatic implant surgery between 2017 and 2022. This research gathered and examined data on follow-up, surgical techniques, complications, demographics, and implant features. There were 100 patients in all. 92% of the implants were successful, and 92 of them survived. Peri-implantitis (20%), soft tissue dehiscence (15%), sinusitis (10%), prosthesis fracture (8%), and infection (5%), were among the biological consequences. In summary, zygomatic implants have the potential to help individuals with severe maxillary atrophy recover, but close observation and effective management of any problems are necessary to maximize results. To enhance patient care and improve treatment regimens, further research is required.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
1.50
自引率
0.00%
发文量
275
审稿时长
34 weeks
期刊介绍: Journal of Pharmacy And Bioallied Sciences is a Quarterly multidisciplinary open access biomedical journal. Journal of Pharmacy And Bioallied Sciences is an international medium of interaction between scientist, academicians and industrial personnel’s.JPBS is now offial publication of OPUBS.
期刊最新文献
The Role of Tele-Orthodontics in Enhancing Patient Compliance and Treatment Monitoring Exploring the Therapeutic Potential of Omega-3 Fatty Acid Supplementation in Dry Eye Syndrome: An In vitro Investigation Enhancing Precision in Endodontic Procedures: An In vitro Investigation of Magnification and Enhanced Visualization Comparative Evaluation of Surgical Techniques for Pterygium Management: An In Vitro Study Schoolchildren’s Musculoskeletal Pain and Backpack Weight Impact on Posture: A Short-Term Study
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1